Placebo News and Research

RSS

Anti-impotence drug found to be ineffective at improving outcomes for IUGR pregnancies

A University of Liverpool led international clinical trial has found an anti-impotence drug to be ineffective at improving outcomes for pregnancies complicated by fetal growth restriction.

8 Dec 2017

New compound targets APOE gene to reduce Alzheimer's damage in mice

People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease.

6 Dec 2017

Study uncovers genes that drive peanut allergy reactions

Mount Sinai researchers have identified six genes that activate hundreds of other genes in children experiencing severe allergic reactions to peanuts.

5 Dec 2017

Investigational ZPIV vaccine found to be safe and immunogenic in trial participants

The investigational Zika purified inactivated virus (ZPIV) vaccine was well-tolerated and induced an immune response in participants, according to initial results from three Phase 1 clinical trials.

5 Dec 2017

Placenta capsules offer little to no benefit for new mothers, study shows

A groundbreaking study by UNLV researchers shows that taking placenta capsules has little to no effect on postpartum mood, maternal bonding, or fatigue, when compared to a placebo.

1 Dec 2017

New targeted treatment could benefit patients with certain pancreatic tumors

Researchers at the University of Cincinnati College of Medicine have shown that a new targeted treatment could benefit patients with certain pancreatic tumors by preventing spread of the cancer and protecting their heart from damage--a direct result of the tumor.

1 Dec 2017

New drugs Erenumab and Fremanezumab show promise for migraine

Migraine headaches affect thousands of Americans and millions worldwide. There are several medications that are being prescribed for migraines and for many these do not work well.

30 Nov 2017

New immunotherapy study shows positive results in chronic migraine sufferers

A new study of fremanezumab, an immunotherapy that counteracts one of the molecules released during migraine, was found successful in reducing the number of days that chronic migraine sufferers experienced headaches.

30 Nov 2017

HPV vaccine shows long-term safety and efficacy in protecting against most virulent strains

A decade of data on hundreds of boys and girls who received the HPV vaccine indicates the vaccine is safe and effective long term in protecting against the most virulent strains of the virus, researchers report.

29 Nov 2017

Synthetic cannabis-like drug found to be safe and effective in treating sleep apnea

A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health. The study was conducted at Northwestern Medicine and the University of Illinois at Chicago.

28 Nov 2017

Treatment of abnormal vaginal microbiota prior to embryo transfer may improve reproductive outcomes

High levels of two specific vaginal bacteria (Atopobium vaginae and Gardnerella vaginalis) serve as diagnostic markers of an abnormal vaginal microbiota that might cause impaired implantation and subsequent poor reproductive outcome.

28 Nov 2017

New study tests pain treatment in humans

Nerve growth factor signals through receptors of the tropomyosin-related kinase (Trk) family, and research in animals has shown that inhibitors of Trks A, B, and C can reduce pain.

27 Nov 2017

Decompression surgery may offer no additional benefit for people with shoulder impingement

Decompression surgery does not reduce shoulder pain any more than placebo surgery for people with shoulder impingement – when the tendon rubs and catches in the joint, according to the first placebo-controlled trial in shoulder surgery published in The Lancet.

22 Nov 2017

UZH leads Europe's largest research on aging

What began in 2012 is now entering its final stages: Europe's largest study on aging. The international research network behind the DO-HEALTH study is led by Heike Bischoff-Ferrari, Professor of Geriatric Medicine and Aging Research at the University of Zurich, and Head of the Department of Geriatrics at the UniversityHospital Zurich and the Waid City Hospital in Zurich, Switzerland.

20 Nov 2017

Trial shows apple allergen as effective treatment option for birch pollen-related apple allergy

The food allergy, which is related to birch pollen, is a very common attendant phenomenon associated with birch pollen allergy - indeed around 70% of those with a birch pollen allergy are also allergic to apples. That amounts to around 280,000 people in Austria.

20 Nov 2017

New study further validates use of vaginal progesterone to decrease risk of preterm birth

A new study published today - World Prematurity Day - in the American Journal of Obstetrics & Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.

17 Nov 2017

Vaginal progesterone decreases the risk of premature birth in women with short cervix

A meta-analysis of placebo-controlled data published today indicates that vaginal progesterone reduces preterm birth and neonatal complications in women with a mid-trimester short cervix.

17 Nov 2017

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

The U.S. Food and Drug Administration today approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed (nephrectomy).

17 Nov 2017

Skin patch offers hope for people with peanut allergy

People who suffer from life-threatening peanut allergies may soon be able to cure their condition by wearing a skin patch, according to the findings of a phase 2 trial.

16 Nov 2017

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.

15 Nov 2017

Placebo News and Research

Anti-impotence drug found to be ineffective at improving outcomes for IUGR pregnancies

New compound targets APOE gene to reduce Alzheimer's damage in mice

Study uncovers genes that drive peanut allergy reactions

Investigational ZPIV vaccine found to be safe and immunogenic in trial participants

Placenta capsules offer little to no benefit for new mothers, study shows

New targeted treatment could benefit patients with certain pancreatic tumors

New drugs Erenumab and Fremanezumab show promise for migraine

New immunotherapy study shows positive results in chronic migraine sufferers

HPV vaccine shows long-term safety and efficacy in protecting against most virulent strains

Synthetic cannabis-like drug found to be safe and effective in treating sleep apnea

Treatment of abnormal vaginal microbiota prior to embryo transfer may improve reproductive outcomes

New study tests pain treatment in humans

Decompression surgery may offer no additional benefit for people with shoulder impingement

UZH leads Europe's largest research on aging

Trial shows apple allergen as effective treatment option for birch pollen-related apple allergy

New study further validates use of vaginal progesterone to decrease risk of preterm birth

Vaginal progesterone decreases the risk of premature birth in women with short cervix

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

Skin patch offers hope for people with peanut allergy

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News